Becton Dickinson Cash on Hand 2010-2024 | BDX
Becton Dickinson cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Becton Dickinson cash on hand for the quarter ending September 30, 2024 was $2.301B, a 54.53% increase year-over-year.
- Becton Dickinson cash on hand for 2024 was $2.301B, a 54.53% increase from 2023.
- Becton Dickinson cash on hand for 2023 was $1.489B, a 27.59% increase from 2022.
- Becton Dickinson cash on hand for 2022 was $1.167B, a 51.46% decline from 2021.
Becton Dickinson Annual Cash on Hand
(Millions of US $) |
| 2024 |
$2,301 |
| 2023 |
$1,489 |
| 2022 |
$1,167 |
| 2021 |
$2,404 |
| 2020 |
$2,937 |
| 2019 |
$620 |
| 2018 |
$1,253 |
| 2017 |
$14,200 |
| 2016 |
$1,907 |
| 2015 |
$1,519 |
| 2014 |
$2,750 |
| 2013 |
$2,608 |
| 2012 |
$2,181 |
| 2011 |
$1,563 |
| 2010 |
$1,744 |
| 2009 |
$1,946 |
Becton Dickinson Quarterly Cash on Hand
(Millions of US $) |
| 2024-09-30 |
$2,301 |
| 2024-06-30 |
$5,338 |
| 2024-03-31 |
$3,221 |
| 2023-12-31 |
$1,236 |
| 2023-09-30 |
$1,489 |
| 2023-06-30 |
$1,032 |
| 2023-03-31 |
$2,074 |
| 2022-12-31 |
$745 |
| 2022-09-30 |
$1,167 |
| 2022-06-30 |
$2,774 |
| 2022-03-31 |
$3,335 |
| 2021-12-31 |
$2,055 |
| 2021-09-30 |
$2,404 |
| 2021-06-30 |
$3,305 |
| 2021-03-31 |
$3,922 |
| 2020-12-31 |
$3,464 |
| 2020-09-30 |
$2,937 |
| 2020-06-30 |
$2,986 |
| 2020-03-31 |
$2,445 |
| 2019-12-31 |
$617 |
| 2019-09-30 |
$620 |
| 2019-06-30 |
$606 |
| 2019-03-31 |
$777 |
| 2018-12-31 |
$1,046 |
| 2018-09-30 |
$1,253 |
| 2018-06-30 |
$1,524 |
| 2018-03-31 |
$1,434 |
| 2017-12-31 |
$1,321 |
| 2017-09-30 |
$14,200 |
| 2017-06-30 |
$13,904 |
| 2017-03-31 |
$911 |
| 2016-12-31 |
$1,283 |
| 2016-09-30 |
$1,907 |
| 2016-06-30 |
$2,046 |
| 2016-03-31 |
$2,022 |
| 2015-12-31 |
$1,629 |
| 2015-09-30 |
$1,519 |
| 2015-06-30 |
$1,718 |
| 2015-03-31 |
$2,129 |
| 2014-12-31 |
$8,784 |
| 2014-09-30 |
$2,750 |
| 2014-06-30 |
$2,639 |
| 2014-03-31 |
$2,626 |
| 2013-12-31 |
$2,513 |
| 2013-09-30 |
$2,608 |
| 2013-06-30 |
$2,299 |
| 2013-03-31 |
$2,421 |
| 2012-12-31 |
$2,512 |
| 2012-09-30 |
$2,181 |
| 2012-06-30 |
$2,188 |
| 2012-03-31 |
$2,112 |
| 2011-12-31 |
$2,694 |
| 2011-09-30 |
$1,563 |
| 2011-06-30 |
$1,921 |
| 2011-03-31 |
$1,858 |
| 2010-12-31 |
$2,247 |
| 2010-09-30 |
$1,744 |
| 2010-06-30 |
$1,445 |
| 2010-03-31 |
$1,258 |
| 2009-12-31 |
$1,458 |
| 2009-09-30 |
$1,946 |
| 2009-06-30 |
$1,752 |
| 2009-03-31 |
$730 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$65.817B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
